Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Megakaryoblastic disorders in children.

Robert B Lorsbach¹

¹Department of Pathology, St Jude Children's Research Hospital, Memphis, TN 38105, USA. robert.lorsbach@stjude.org

American Journal of Clinical Pathology

|February 5, 2005

Summary

Pediatric acute myeloid leukemia shares similarities with adult forms, but megakaryoblastic disorders are unique to children. Recent research offers molecular insights for classifying these childhood blood cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Monocytic transition in B-lymphoblastic leukaemia with a DUX4 rearrangement.

British journal of haematology·2026

Same author

Maternal-Fetal Transmission of Diffuse Large B-Cell Lymphoma.

Pediatric blood & cancer·2025

Same author

Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).

Blood cells, molecules & diseases·2021

Same author

VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects.

American journal of human genetics·2020

Same author

High-risk LCH in infants is serially transplantable in a xenograft model but responds durably to targeted therapy.

Blood advances·2020

Same author

Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.

Pediatric blood & cancer·2018

Area of Science:

Pediatric Hematology/Oncology
Molecular Pathology
Cancer Genomics

Background:

Acute myeloid leukemia (AML) is a common childhood cancer, with a significant portion being acute megakaryoblastic leukemia.
While AML in children often mirrors adult presentations, specific megakaryoblastic proliferations are predominantly observed in pediatric patients.
The underlying pathogenetic mechanisms of these pediatric megakaryoblastic disorders have historically been unclear.

Purpose of the Study:

To elucidate the pathogenetic mechanisms of pediatric megakaryoblastic disorders.
To establish a molecular basis for classifying primary megakaryoblastic disorders in children.
To enhance understanding of unique childhood leukemia subtypes.

Main Methods:

Review of recent advances in understanding the pathogenesis of pediatric megakaryoblastic disorders.
Analysis of molecular insights into disease development.
Correlation of molecular findings with clinical and pathological features.

Main Results:

Significant progress has been made in understanding the molecular underpinnings of pediatric megakaryoblastic proliferations.
These advances provide a foundation for a more precise, molecularly-driven classification system.
The findings highlight distinct pathogenetic pathways in childhood leukemia.

Conclusions:

Recent molecular discoveries offer crucial insights into the pathogenesis of pediatric megakaryoblastic disorders.
A molecular classification framework is now feasible for these unique childhood leukemias.
This molecular understanding is essential for improved diagnosis and potential targeted therapies.

Related Experiment Videos